Genpact President and CEO Kalra Balkrishan sold 10,000 shares at $36.79 per share on 2026-09-14. For investors, the transaction represented about 2.0% of his prior Genpact shareholding, while his ownership following the sale stood at 501,114 shares.
Key Highlights
- The transaction was recorded on 14 September 2026 under code S, which denotes a sale.
- Balkrishan retained 501,114 Genpact shares after the transaction.
- The sale represented about 2.0% of his prior shareholding.
Sale Recorded Under Transaction Code S
The transaction was dated 14 September 2026, and Balkrishan’s remaining ownership was 501,114 shares. The transaction involved 10,000 Genpact LTD (NYSE: G) shares at $36.79 per share. The transaction price applies to each share sold. Genpact LTD’s reported transaction date was 14 September 2026.
Sale Represented About 2.0% of Prior Holding
The 10,000-share transaction represented about 2.0% of Balkrishan’s prior shareholding in Genpact LTD. His ownership following the transaction stood at 501,114 shares. The reported remaining holding was stated after the sale.
FAQs
Q: How many Genpact shares did Kalra Balkrishan sell?
A: Kalra Balkrishan sold 10,000 Genpact LTD shares at $36.79 per share on 14 September 2026. The transaction was classified under code S.
Q: How many Genpact shares does CEO Kalra Balkrishan own after the sale?
A: Following the sale, Balkrishan’s remaining ownership was 501,114 Genpact LTD shares.
Q: What percentage of Kalra Balkrishan’s prior holding did the sale represent?
A: The sale represented about 2.0% of Kalra Balkrishan’s prior Genpact LTD shareholding. The transaction involved 10,000 shares at $36.79 per share.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.